Fig. 4From: Inferring pathway dysregulation in cancers from multiple types of omic dataAUC scores for each omic type from the HER2 analysis. GSOA was applied to various types of omic data from TCGA. HER2+ breast cancer samples were compared against HER2− samples. Predictions based on RNA-sequencing data attained the highest accuracyBack to article page